• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Business

Takeda confirms Nycomed acquisition

One day after issuing a denial (for the second time) regarding rumors of a deal for Nycomed, Takeda has confirmed its acquisition of the Swiss company for €9.6 billion (~$13.7 billion). The deal does not include Nycomed's US dermatology business, which will be spun off. Yasuchika Hasegawa, President & CEO of Takeda, said: “Takeda is committed to transforming our … [Read more...] about Takeda confirms Nycomed acquisition

Daiichi-Sankyo and Regency launch Sprix nasal spray

Regency Therapeutics, a division of Luitpold Pharmaceuticals, and Daiichi-Sankyo, Inc. have announced the launch of Sprix ketorolac tromethamine nasal spray "for the short-term (up to 5 days) management of moderate to moderately severe pain that requires analgesia at the opioid level." The US FDA approved Sprix in May 2010. In December 2010, Luitpold, a subsidiary of … [Read more...] about Daiichi-Sankyo and Regency launch Sprix nasal spray

GSK and AstraZeneca collaborate on research center

GSK and AstraZeneca have announced that the two companies, along with the University of Manchester, are working together to create the Manchester Collaborative Centre for Inflammation Research (MCCIR) to facilitate translational research in inflammatory diseases, including COPD and asthma. The center will recruit scientists in time to open the new facility at the … [Read more...] about GSK and AstraZeneca collaborate on research center

Takeda reportedly pursuing Nycomed

According to reports, Takeda Pharmaceutical is looking to buy Swiss pharma company Nycomed, which manufactures several OINDPs, including the Alvesco ciclesonide MDI and Omnaris ciclesonide nasal spray. Nycomed is also developing a ciclesonide HFA nasal aerosol in partnership with Sunovion (formerly Sepracor); that product is currently in Phase 3. Takeda is … [Read more...] about Takeda reportedly pursuing Nycomed

MannKind reveals details of latest FDA review meeting

Five days after its end of review meeting with the FDA on May 4 regarding its Afrezza inhaled insulin, MannKind Corporation held a conference call to update its progress and financial situation. During the call, Alfred Mann characterized the meeting as "positive and collaborative, resulting in a redirection of the Type 2 trial that should enable us to support use of … [Read more...] about MannKind reveals details of latest FDA review meeting

Hovione announces successful GMP inspections

Over the past 8 months, says API developer and manufacturer Hovione, its facilities have undergone a total of 6 inspections by the US FDA, the Japanese PMDA, and the Portuguese authorities. Pre-approval inspections for 2 new products for customer synthesis, and for existing molecules used in new formulations, took place at the company's facilities in New Jersey, … [Read more...] about Hovione announces successful GMP inspections

Pfizer returns rights to Rigel’s inhaled syk inhibitor

Rigel Pharmaceuticals says it will assume development responsibilities for R343, an inhaled syk inhibitor for the treatment of allergic asthma after Pfizer returned all rights to the program. Pfizer had licensed R343, along with other inhaled syk inhibitors, from Rigel in 2005. R343 works by binding to syk, a protein tyrosine kinase in mast cells involved in IgE … [Read more...] about Pfizer returns rights to Rigel’s inhaled syk inhibitor

GSK makes additional investment in Theravance

According to reports, GlaxoSmithKline has invested an additional $6.7 million in Theravance, its partner in developing a number of inhaled asthma and COPD drugs. The purchase of common stock gives GSK approximately 19% of Theravance's outstanding shares. GSK and Theravance have worked together on inhalation product development since 2002 and have their Relovair … [Read more...] about GSK makes additional investment in Theravance

Prosonix particle technology now in use at Sterling

Steroid manufacturers Sterling S.r.l., located in Perugia, Italy, is now producing APIs for respiratory delivery using particle engineering technology supplied by Prosonix. A two-year collaboration between the two companies has resulted in a retrofit of existing Sterling equipment at the company's FDA-approved facility. The Prosonix crystallization technology … [Read more...] about Prosonix particle technology now in use at Sterling

MicroDose Therapeutx reaches milestone in Novartis agreement

MicroDose Therapeutx has announced that it has achieved a milestone that "signals the successful incorporation of MicroDose’s DPI technology into a Novartis platform pulmonary device" and triggers a milestone payment from Novartis. The two companies entered into a development and licensing agreement for five products in June 2006. According to a press release at … [Read more...] about MicroDose Therapeutx reaches milestone in Novartis agreement

  • « Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Interim pages omitted …
  • Page 152
  • Next Page »

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Intertek banner
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews